Bain Capital Life Sciences Investors, LLC Aclaris Therapeutics, Inc. Transaction History
Bain Capital Life Sciences Investors, LLC
- $489 Million
- Q2 2024
A detailed history of Bain Capital Life Sciences Investors, LLC transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, Bain Capital Life Sciences Investors, LLC holds 1,000,000 shares of ACRS stock, worth $1.13 Million. This represents 0.23% of its overall portfolio holdings.
Number of Shares
1,000,000
Previous 3,000,000
66.67%
Holding current value
$1.13 Million
Previous $3.72 Million
70.43%
% of portfolio
0.23%
Previous 0.56%
Shares
4 transactions
Others Institutions Holding ACRS
# of Institutions
100Shares Held
52.2MCall Options Held
32.4KPut Options Held
3.3K-
Bml Capital Management, LLC Zionsville, IN13MShares$14.7 Million10.2% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.69MShares$5.3 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.34MShares$3.77 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY3.32MShares$3.75 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD2.75MShares$3.11 Million0.09% of portfolio
About Aclaris Therapeutics, Inc.
- Ticker ACRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 66,671,800
- Market Cap $75.3M
- Description
- Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...